FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34621111000001100: Olumiant 2mg tablets (Eli Lilly and Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Aug 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104700701000001117 Olumiant 2mg tablets (Eli Lilly and Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104700801000001114 Olumiant 2mg tablets (Eli Lilly and Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Is a Baricitinib 2mg tablets true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has active ingredient Substance with Janus kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has specific active ingredient Baricitinib false Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Is a Olumiant true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has specific active ingredient Baricitinib true Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Olumiant 2mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has AMP True Olumiant 2mg tablets (Eli Lilly and Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start